TR200906997A1 - Pramipeksol farmasötik bileşimleri. - Google Patents

Pramipeksol farmasötik bileşimleri.

Info

Publication number
TR200906997A1
TR200906997A1 TR2009/06997A TR200906997A TR200906997A1 TR 200906997 A1 TR200906997 A1 TR 200906997A1 TR 2009/06997 A TR2009/06997 A TR 2009/06997A TR 200906997 A TR200906997 A TR 200906997A TR 200906997 A1 TR200906997 A1 TR 200906997A1
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
pramipexole
pharmaceutically acceptable
pramipexole pharmaceutical
solvate
Prior art date
Application number
TR2009/06997A
Other languages
English (en)
Inventor
T�Rkyilmaz Al�
Al� Turp Hasan
�M�T ��Fter Musa
Yelken G�Lay
�Ner Levent
Toks�Z Ahmet
Original Assignee
Sanovel �La� San. Ve T�C. A. �.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel �La� San. Ve T�C. A. �. filed Critical Sanovel �La� San. Ve T�C. A. �.
Priority to TR2009/06997A priority Critical patent/TR200906997A1/tr
Priority to ES10175596T priority patent/ES2375265T3/es
Priority to EP10175596A priority patent/EP2295040B1/en
Priority to AT10175596T priority patent/ATE527991T1/de
Publication of TR200906997A1 publication Critical patent/TR200906997A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, pramipeksol veya onun farmasotik olarak kabul edilebilir bir tuzu, solvatı ve hidratından meydana gelen yeni bir farmasotik bileşim ile ilgili olup, sodyum nişasta glikolat ve dibazik kalsiyum fosfat dihidrat ile birlikte en az bir adet farmasotik olarak kabul edılir yardımcı madde içeren, oral uygulanabilen preparatları ve kullanımları ile ilgilidir.
TR2009/06997A 2009-09-11 2009-09-11 Pramipeksol farmasötik bileşimleri. TR200906997A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/06997A TR200906997A1 (tr) 2009-09-11 2009-09-11 Pramipeksol farmasötik bileşimleri.
ES10175596T ES2375265T3 (es) 2009-09-11 2010-09-07 Composiciones farmacéuticas de pramipexol.
EP10175596A EP2295040B1 (en) 2009-09-11 2010-09-07 Pharmaceutical compositions of pramipexole
AT10175596T ATE527991T1 (de) 2009-09-11 2010-09-07 Pharmazeutische zusammensetzungen von pramipexol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/06997A TR200906997A1 (tr) 2009-09-11 2009-09-11 Pramipeksol farmasötik bileşimleri.

Publications (1)

Publication Number Publication Date
TR200906997A1 true TR200906997A1 (tr) 2011-03-21

Family

ID=41665020

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/06997A TR200906997A1 (tr) 2009-09-11 2009-09-11 Pramipeksol farmasötik bileşimleri.

Country Status (4)

Country Link
EP (1) EP2295040B1 (tr)
AT (1) ATE527991T1 (tr)
ES (1) ES2375265T3 (tr)
TR (1) TR200906997A1 (tr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016203348A1 (de) 2016-03-01 2017-09-07 Hp Pelzer Holding Gmbh Mehrlagiger Akustik- und/oder Versteifungsvliesstoff
DE102019104847A1 (de) * 2019-02-26 2020-08-27 Adler Pelzer Holding Gmbh Materialstruktur eines Nadelvlieses
WO2020216745A1 (de) 2019-04-23 2020-10-29 Adler Pelzer Holding Gmbh Absorptiver vernadelter schichtverbund

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181905B (zh) * 2011-12-27 2015-10-28 重庆安格龙翔医药科技有限公司 一种制备盐酸普拉克索片剂的工艺
CN103040780B (zh) * 2013-01-04 2015-02-25 杭州朱养心药业有限公司 快速崩解的普拉克索片剂药物组合物及其制备方法
CN103961325B (zh) * 2013-02-03 2018-08-21 南京圣和药业股份有限公司 普拉克索片剂的制备方法和由此获得的片剂及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2008023027A2 (en) * 2006-08-24 2008-02-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing pramipexole dihydrochloride tablets with high storage stability
WO2008122638A2 (en) * 2007-04-10 2008-10-16 Boehringer Ingelheim International Gmbh Process for preparing pramipexole dihydrochloride tablets
WO2008129043A1 (en) * 2007-04-24 2008-10-30 Boehringer Ingelheim International Gmbh Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE19701619B4 (de) 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
DE10137453A1 (de) 2001-08-02 2003-02-20 Boehringer Ingelheim Pharma Pramlpexol als Antikonvulsivum
DE10137633A1 (de) 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Pramipexol zur Behandlung von ADHD
WO2008145252A1 (en) 2007-05-25 2008-12-04 Boehringer Ingelheim International Gmbh Pharmaceutical formulation comprising pramipexole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2008023027A2 (en) * 2006-08-24 2008-02-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing pramipexole dihydrochloride tablets with high storage stability
WO2008122638A2 (en) * 2007-04-10 2008-10-16 Boehringer Ingelheim International Gmbh Process for preparing pramipexole dihydrochloride tablets
WO2008129043A1 (en) * 2007-04-24 2008-10-30 Boehringer Ingelheim International Gmbh Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016203348A1 (de) 2016-03-01 2017-09-07 Hp Pelzer Holding Gmbh Mehrlagiger Akustik- und/oder Versteifungsvliesstoff
WO2017148711A1 (de) 2016-03-01 2017-09-08 Hp Pelzer Holding Gmbh Mehrlagiger akustik- und/oder versteifungsvliesstoff
DE102019104847A1 (de) * 2019-02-26 2020-08-27 Adler Pelzer Holding Gmbh Materialstruktur eines Nadelvlieses
WO2020173757A1 (de) 2019-02-26 2020-09-03 Adler Pelzer Holding Gmbh Materialstruktur eines nadelvlieses
WO2020216745A1 (de) 2019-04-23 2020-10-29 Adler Pelzer Holding Gmbh Absorptiver vernadelter schichtverbund

Also Published As

Publication number Publication date
EP2295040B1 (en) 2011-10-12
ATE527991T1 (de) 2011-10-15
EP2295040A1 (en) 2011-03-16
ES2375265T3 (es) 2012-02-28

Similar Documents

Publication Publication Date Title
CY1124219T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τοπικο αναiσθητiκο οπως η βουπιβακαϊνη για τοπικη χορηγηση στο στομα ή τον φαρυγγα
TR200906997A1 (tr) Pramipeksol farmasötik bileşimleri.
MY167135A (en) Fused heterocyclic derivatives and methods of use
MY159615A (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
BR112012021681A2 (pt) rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração.
ATE517882T1 (de) Chinolinderivate
IN2014DN03206A (tr)
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
CY1115043T1 (el) Φαρμακευτικο σκευασμα
MX2009001659A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea.
MY187718A (en) Pharmaceutical formulations
WO2011047173A3 (en) Pharmaceutical compositions for oral administration
IN2012DN02502A (tr)
MX2011013884A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
WO2010129057A8 (en) Tetracycline compounds
IN2012DN03428A (tr)
CY1119710T1 (el) Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες
BR112012013199A2 (pt) composto, composição farmacêutica, e , uso de um composto
WO2010132670A3 (en) Pentacycline compounds
NZ600107A (en) Formulations, salts and polymorphs of transnorsertraline and uses thereof
TR200907554A1 (tr) Oral yolla dağılan pramıpexole bileşimleri.
IN2014DN11023A (tr)
BR112013012665A2 (pt) composto de fórmula (i), ou um sal, pró-droga ou solvato do mesmo e composição farmacêutica
TW200640933A (en) Anthelmintic compounds
CO6331429A2 (es) Derivados de 5-(4-metanosulfonil-fenil)-tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas